239 related articles for article (PubMed ID: 15523131)
1. Antibody levels against polioviruses in children following Pulse Polio Immunization Program.
Hasan AS; Malik A; Shukla I; Malik MA
Indian Pediatr; 2004 Oct; 41(10):1040-4. PubMed ID: 15523131
[TBL] [Abstract][Full Text] [Related]
2. Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
Prevots DR; Pascual FB; Angellili ML; Brayden R; Irigoyen M; Larussa P; Sawyer M; Baughman AL; Pallansch MA
Pediatr Infect Dis J; 2004 Dec; 23(12):1130-6. PubMed ID: 15626951
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
4. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria.
Adewumi MO; Donbraye E; Odaibo GN; Bakarey AS; Opaleye OO; Olaleye DO
J Trop Pediatr; 2006 Apr; 52(2):92-5. PubMed ID: 16014758
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological characteristics of poliomyelitis in Delhi, 1997.
Singh J; Khare S; Bhatia R; Jain DC; Sokhey J
Indian Pediatr; 1999 Dec; 36(12):1211-9. PubMed ID: 10745362
[TBL] [Abstract][Full Text] [Related]
7. [A seroepidemiological study on the level of immunological coverage in a nomadic population in Rome].
Porta D; Chierchini P; Bruno L; Fiore L; Cristofaro G; Amato C; Catone S; Gentili G; Sangalli M; Forastiere F
Epidemiol Prev; 1997; 21(1):48-53. PubMed ID: 9157025
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of poliovirus antibodies among children in a Dominican community--Puerto Rico, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):580-1. PubMed ID: 15959453
[TBL] [Abstract][Full Text] [Related]
9. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau.
Aaby P; Hedegaard K; Sodemann M; Nhante E; Veirum JE; Jakobsen M; Lisse I; Jensen H; Sandström A
Vaccine; 2005 Feb; 23(14):1746-51. PubMed ID: 15705481
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco].
Caidi H; Bennis IF; Mouan N; El Aouad R
East Mediterr Health J; 2004; 10(4-5):474-81. PubMed ID: 16335637
[TBL] [Abstract][Full Text] [Related]
11. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to pulse polio immunization in Aligarh.
John TJ
Indian Pediatr; 2005 Jan; 42(1):91-2. PubMed ID: 15695879
[No Abstract] [Full Text] [Related]
15. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria.
Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M
J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
[TBL] [Abstract][Full Text] [Related]
17. Oral polio vaccines have not yet covered West Africa: survey of immunization coverage conducted in Niger.
Akano Y; Ando H; Tanaka A; Uchida H; Fujii K; Takayanagi M; Magagi A; Nakane M; Nakano T
Jpn J Infect Dis; 2004 Jun; 57(3):121-3. PubMed ID: 15218224
[TBL] [Abstract][Full Text] [Related]
18. Pulse polio programme: an overview of parent's perception.
Rasania SK; Sachdev TR
J Commun Dis; 2000 Dec; 32(4):275-83. PubMed ID: 11668938
[TBL] [Abstract][Full Text] [Related]
19. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
[TBL] [Abstract][Full Text] [Related]
20. OPV cannot eradicate polio from India: do we need any further evidence?
Paul Y
Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
